Novo Nordisk A/S (NYSE:NVO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month target price among brokerages […]
Novo Nordisk on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and development, to.
Novo Nordisk A/S (NYSE:NVO – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 3,151,400 shares changed hands during trading, an increase of 3% from the previous session’s volume of 3,052,158 shares.The stock last traded at $91.79 and had previously closed at $94.73. Analyst Ratings Changes A number of equities analysts recently commented […]